Medacta wins FDA nod for anatomic, reverse shoulder repair components

This article was originally published here
Share

Medacta

Medacta said today it won FDA clearance for its Anatomic shoulder and reverse shoulder components designed as part of its Medacta shoulder system.

The Chicago-based company touted that the 1st successful procedure using the device was recently performed at Northwestern Memorial Hospital by Dr. Matthew Saltzman.

“The procedure went very well. The Medacta Shoulder System’s instrumentation and implants allow for impressive anatomic restoration, resulting in an efficient surgery and, hopefully, improved patient outcomes,” Dr. Saltzman said in a press release.

The Medacta shoulder system was released in February this year and is a modular platform which features a wide range of sizes and options for a range of compatibility with different anatomies, the company said.

“The new Medacta Shoulder System is a continuation of our effort to improve orthopedic implant design and configurability for the benefit of both surgeons and their patients. This latest surgery in the United States marks a milestone for Medacta in line with our company’s patient-centric vision and the same ambition that has helped us become a leader in knee, hip, and spine technology,” Medacta exec VP Francesco Siccardi said in a prepared statement.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply